Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: rationale and design

BACKGROUND: Ischemic stroke and other vascular outcomes occur in 10–20% of patients in the 3 months following a TIA or minor ischemic stroke, and many are disabling. The highest risk period for these outcomes is the early hours and days immediately following the ischemic event. Aspirin is the most c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Stroke
Hauptverfasser: Johnston, S. Claiborne, Easton, J. Donald, Farrant, Mary, Barsan, William, Battenhouse, Holly, Conwit, Robin, Dillon, Catherine, Elm, Jordan, Lindblad, Anne, Morgenstern, Lewis, Poisson, Sharon N., Palesch, Yuko
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4412261/
https://ncbi.nlm.nih.gov/pubmed/23879752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijs.12129
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge